EMEA-002234-PIP01-17-M02 - paediatric investigation plan
Purified inactivated rabies virus (WISTAR PM/WI 38-1503-3M strain)
PIPHuman
Key facts
- Active Substance
- Purified inactivated rabies virus (WISTAR PM/WI 38-1503-3M strain)
- Therapeutic area
- Infections and infestations
- Decision number
- P/0051/2024
- PIP number
- EMEA-002234-PIP01-17-M02
- Pharmaceutical form(s)
- Powder and solvent for suspension for injection
- Condition(s) / indication(s)
- Prevention of rabies viral infection
- Route(s) of administration
- Intramuscular use
- Intradermal use
- Contact for public enquiries
Sanofi Pasteur Europe
Email: contact-us@sanofi.com
Tel. +33 169745789
- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date